Chemotherapy

Two-drug combination boosts survival in patients with metastatic prostate cancer

By

A combination therapy increased survival rates for individuals with newly diagnosed metastatic, hormone-sensitive prostate cancer.

Effects of glioblastoma treatments on healthy brain tissue continues after treatment is completed

By

The first study to examine the effects of combined radiation and chemotherapy on the healthy brain tissue of glioblastoma patients has revealed specific structural brain changes.

Safest timing of pegfilgrastim administration seems to be 72 hours after chemo

Safest timing of pegfilgrastim administration seems to be 72 hours after chemo

Safest timing of pegfilgrastim administration based on white blood cell (WBC) count seems to be 72 hours following chemotherapy.

Port functionality with irinotecan administration

Port functionality with irinotecan administration

By

Subcutaneous power ports seem to rarely function properly when administering irinotecan but function properly when the regimen changes. Is there an explanation for why this happens?

Standard IV administration of KCL

Standard IV administration of KCL

By

Is there a standard process for administering KCL through an IV?

Practices should be evaluated for cytotoxic chemotherapy extravasation

Practices should be evaluated for cytotoxic chemotherapy extravasation

This literature review sought to analyze the quality of evidence that supports management practices of cytotoxic drug extravasation.

Chemotherapy less likely to benefit older patients with breast cancer

Chemotherapy less likely to benefit older patients with breast cancer

Chemotherapy does not improve survival for older women with breast cancer.

Activated neutrophils may trigger potentially fatal hemorrhage associated with some cancer treatments

By

Blocking the passage of immune cells could prevent dangerous complications in patients undergoing transplants or chemotherapy.

Intraperitoneal chemotherapy improves ovarian cancer survival

Intraperitoneal chemotherapy improves ovarian cancer survival

Despite survival benefits, only 41 percent of suitable candidates actually receive the therapy.

New combination could make cancer more sensitive to chemotherapy

New combination could make cancer more sensitive to chemotherapy

By

Combining chemotherapy with new drugs that target a protein that helps cancer cells withstand chemotherapy could improve treatment.

For patients with terminal cancer, chemotherapy does not improve quality of life

For patients with terminal cancer, chemotherapy does not improve quality of life

Chemotherapy administered to patients with cancer who are near death does not improve quality of life.

Chemotherapy-related decline in cognitive function correlated with biomarkers

Chemotherapy-related decline in cognitive function correlated with biomarkers

By

Research indicates a connection between chemo-related cognitive function decline and molecular immune biomarkers, genetic aging, and neurotransmitter markers.

The impact of 5-hydroxytryptamine-receptor antagonists on chemotherapy treatment adherence, treatment delay, and nausea and vomiting

The impact of 5-hydroxytryptamine-receptor antagonists on chemotherapy treatment adherence, treatment delay, and nausea and vomiting

[Cancer Management and Research] This research examines the incidence of chemotherapy-induced nausea/vomiting (CINV) and treatment delay among patients receiving palonosetron versus other 5-hydroxytryptamine receptor antagonist (5-HT3 RA) antiemetics.

Chemotherapy dosages in overweight or obese patients with ovarian cancer

By

Overweight or obese patients with ovarian cancer are typically given lower per-pound chemotherapy doses to reduce toxic side effects, which could impact their survival chances.

Hydration regimens for cisplatin

Hydration regimens for cisplatin

By

Is there evidence to support adding potassium magnesium and mannitol to the hydration regimens for cisplatin?

Stress hormones could undermine breast cancer therapy

By

The stress hormones often used to treat the side effects of chemotherapy could have the side effect of making effective cancer drugs fail sooner in some women with breast cancer, according to new research.

Addition of aprepitant may improve vomiting control in patients receiving oxaliplatin

Addition of aprepitant may improve vomiting control in patients receiving oxaliplatin

A three-drug combination antiemetic therapy including aprepitant or fosaprepitant improved the prevention rate of nausea and vomiting.

Chemotherapy may be the preferred option for some patients with advanced prostate cancer

Chemotherapy may be the preferred option for some patients with advanced prostate cancer

By

In a small clinical trial, scientists found that men with advanced prostate cancer and detection of androgen receptor splice variant-7 (AR-V7) respond to chemotherapy just as well as men who lack the variant.

Low-quality evidence found to support use of cannabinoids for CINV

Low-quality evidence found to support use of cannabinoids for CINV

Moderate-quality evidence to support the use of cannabinoids for the treatment of chronic pain.

Multimodality treatment for metastatic lung cancer with surgery may improve survival

By

Patients with an advanced form of metastatic non-small cell lung cancer (NSCLC) may benefit from surgical resection of all or part of the lung if combined with chemotherapy and radiation therapy.

Optimal nurse:patient ratio for patients on IL-2

Optimal nurse:patient ratio for patients on IL-2

By

What is the best practice recommendation for nurse-to-patient ratio for patients receiving IL-2?

Combining targeted drug with chemotherapy prolongs life for patients with B-cell lymphoma

By

The combination of ibrutinib and chemotherapy (bendamustine and rituximab [BR]) was found to reduce the risk of death by nearly 80% in patients with previously treated CLL or SLL.

Immunotherapy drug improves survival for common form of lung cancer

By

Individuals with squamous non-small cell lung cancer (NSCLC) fared better when receiving nivolumab when compared to those receiving more standard chemotherapy, according to a recent clinical trial.

Intravenous nutrition source could reduce side effects of chemotherapy

By

The side effects caused by potent chemotherapy regimens could possibly be considerably lessened by use of an intravenous nutrition source.

Biomarker may boost ovarian cancer response to chemotherapy

By

Researchers have identified a molecule that may play a central role in chemotherapy resistance in patients with the most common ovarian cancer.

Chemotherapy before surgery benefits patients with advanced ovarian cancer

By

Women with advanced ovarian cancer have fewer side effects and tend to have a better quality of life if given chemotherapy before surgery.

Managing capecitabine-associated mucositis

Managing capecitabine-associated mucositis

By

How should severe mucositis from capecitabine (Xeloda) be managed?

Exercise throughout chemotherapy reduces cognitive impairment, inflammation

Exercise throughout chemotherapy reduces cognitive impairment, inflammation

Patients with cancer who exercise throughout chemotherapy had reduced chronic inflammation and cognitive impairment.

Optimal Sequencing for Chemotherapy and Radium 223 for Prostate Cancer Under Debate

Optimal Sequencing for Chemotherapy and Radium 223 for Prostate Cancer Under Debate

By

When is chemotherapy or radium 223 the optimal treatment for men with advanced prostate cancer?

Treatment factors examined that are associated with improved survival in oral cavity cancer

By

Neck dissection of lymph nodes and treatment at academic or research institutions are both associated with improved survival for patients with stages I and II oral cavity squamous cell cancer, according to recent research.

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs